Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Phase I / II Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer

NCT01188707 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT01188707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01188707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Phase I / II Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer
Lead sponsor
Herlev Hospital
Phase
Phase 1/2
Overall status
Terminated
Start date
October 1, 2010
Completion date
June 30, 2011
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer